Alcidion GroupASX:ALC +1.05% EBITDA Margin % is 15.55% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Alcidion Group ranks better than 78.89% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Alcidion Group's EBITDA for the
six
months ended in Dec. 2025 was A$3.96 Mil. Alcidion Group's Revenue for the
six
months ended in Dec. 2025 was A$25.47 Mil. Therefore, Alcidion Group's EBITDA margin for the quarter that ended in Dec. 2025 was 15.55%.
Alcidion Group (ASX:ALC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Alcidion Group EBITDA Margin % Related Terms
Alcidion Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Alcidion Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Alcidion Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Alcidion Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a EBITDA Margin % of 15.55% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Alcidion Group and its competitors. According to the industry distribution chart, Alcidion Group ranks #141 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 21.1%.
Is Alcidion Group's EBITDA Margin % too high?
Alcidion Group's current EBITDA Margin % is 15.55%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Alcidion Group's value of 15.55% is 52.3% above this industry median. Based on the distribution chart, Alcidion Group ranks #141 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Alcidion Group's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #141 out of 668 companies for EBITDA Margin %. This places Alcidion Group in the top 21% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Alcidion Group's value of 15.55% is 52.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current EBITDA Margin % of 15.55% is 52.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current EBITDA Margin % is 15.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 20% below its estimated fair value. The current EBITDA Margin % is 15.55% and 52.3% above the Healthcare Providers & Services industry median of 10.21. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current EBITDA Margin % is 15.55% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 